Literature DB >> 21906793

Induced sputum proteome in healthy subjects and asthmatic patients.

Sina A Gharib1, Elizabeth V Nguyen, Ying Lai, Jessica D Plampin, David R Goodlett, Teal S Hallstrand.   

Abstract

BACKGROUND: Asthma is a heterogeneous disease characterized by abnormal airway pathophysiology and susceptibility to different stimuli, as exemplified by a subset of patients with exercise-induced bronchoconstriction. Induced sputum provides a noninvasive method to sample airway biofluids that are enriched in proteins.
OBJECTIVE: We hypothesized that novel mechanisms in the pathogenesis of asthma might be revealed by studying the patterns of protein expression in induced sputum.
METHODS: We used shotgun proteomics to analyze induced sputum from 5 healthy subjects and 10 asthmatic patients, including 5 with exercise-induced bronchoconstriction. Differential protein expression among asthmatic patients, asthma subphenotypes, and control subjects was determined by using spectral counting and computational methods.
RESULTS: Using Gene Ontology analysis, we defined the functional landscape of the induced sputum proteome and applied network analysis to construct a protein interaction map for this airway compartment. Shotgun proteomics analysis identified a number of proteins the differential enrichment or depletion of which robustly distinguished asthmatic patients from healthy control subjects and captured the effects of exercise on induced sputum proteome. Functional and network analysis identified key processes, including proteolytic activity, that are known contributors to airway remodeling. Importantly, this approach highlighted previously unrecognized roles for differentially expressed proteins in pathways implicated in asthma, such as modulation of phospholipase A(2) by secretoglobin, a putative role for S100A8/9 in human asthma, and selective upregulation of complement component 3a in response to exercise in asthmatic patients.
CONCLUSION: Computationally intensive analysis of induced sputum proteome is a powerful approach to understanding the pathophysiology of asthma and a promising methodology to investigating other diseases of the airways.
Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21906793      PMCID: PMC4065239          DOI: 10.1016/j.jaci.2011.07.053

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  56 in total

1.  Clara cell protein-positive epithelial cells are reduced in small airways of asthmatics.

Authors:  N Shijubo; Y Itoh; T Yamaguchi; A Imada; M Hirasawa; T Yamada; T Kawai; S Abe
Journal:  Am J Respir Crit Care Med       Date:  1999-09       Impact factor: 21.405

2.  Creating the gene ontology resource: design and implementation.

Authors: 
Journal:  Genome Res       Date:  2001-08       Impact factor: 9.043

3.  Relationship between group-specific component protein and the development of asthma.

Authors:  Shin-Hwa Lee; Kyung-Hun Kim; Jin-Moo Kim; Sang-Hyuk Yoon; Tae Hoon Kim; Sung-Woo Park; Jong-Sook Park; Soo-Taek Uh; Ho Sung Lee; Yong Hoon Kim
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

4.  Genome-specific gas-phase fractionation strategy for improved shotgun proteomic profiling of proteotypic peptides.

Authors:  Alexander Scherl; Scott A Shaffer; Gregory K Taylor; Hemantha D Kulasekara; Samuel I Miller; David R Goodlett
Journal:  Anal Chem       Date:  2008-01-23       Impact factor: 6.986

Review 5.  Markers of airway inflammation in pulmonary diseases assessed by induced sputum.

Authors:  S Dragonieri; O Tongoussouva; A Zanini; A Imperatori; A Spanevello
Journal:  Monaldi Arch Chest Dis       Date:  2009-09

6.  Complement activation by diesel exhaust particles (DEP).

Authors:  H Kanemitsu; S Nagasawa; M Sagai; Y Mori
Journal:  Biol Pharm Bull       Date:  1998-02       Impact factor: 2.233

7.  Genetic influences on asthma susceptibility in the developing lung.

Authors:  Nicole Carpe; Isabel Mandeville; Leslie Ribeiro; Andre Ponton; James G Martin; Alvin T Kho; Jen-Hwa Chu; Kelan Tantisira; Scott T Weiss; Benjamin A Raby; Feige Kaplan
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-29       Impact factor: 6.914

8.  Relationship between levels of secreted phospholipase A₂ groups IIA and X in the airways and asthma severity.

Authors:  T S Hallstrand; Y Lai; Z Ni; R C Oslund; W R Henderson; M H Gelb; S E Wenzel
Journal:  Clin Exp Allergy       Date:  2011-01-24       Impact factor: 5.018

9.  Cutting edge: altered pulmonary eosinophilic inflammation in mice deficient for Clara cell secretory 10-kDa protein.

Authors:  L C Chen; Z Zhang; A C Myers; S K Huang
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

10.  STRING 8--a global view on proteins and their functional interactions in 630 organisms.

Authors:  Lars J Jensen; Michael Kuhn; Manuel Stark; Samuel Chaffron; Chris Creevey; Jean Muller; Tobias Doerks; Philippe Julien; Alexander Roth; Milan Simonovic; Peer Bork; Christian von Mering
Journal:  Nucleic Acids Res       Date:  2008-10-21       Impact factor: 16.971

View more
  21 in total

Review 1.  Role of cells and mediators in exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand; William A Altemeier; Moira L Aitken; William R Henderson
Journal:  Immunol Allergy Clin North Am       Date:  2013-03-29       Impact factor: 3.479

Review 2.  RAGE: a new frontier in chronic airways disease.

Authors:  Maria B Sukkar; Md Ashik Ullah; Wan Jun Gan; Peter A B Wark; Kian Fan Chung; J Margaret Hughes; Carol L Armour; Simon Phipps
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 3.  Update on clinical inflammometry for the management of airway diseases.

Authors:  Parameswaran Nair
Journal:  Can Respir J       Date:  2013 Mar-Apr       Impact factor: 2.409

Review 4.  Proteomics: Clinical and research applications in respiratory diseases.

Authors:  Katy C Norman; Bethany B Moore; Kelly B Arnold; David N O'Dwyer
Journal:  Respirology       Date:  2018-08-13       Impact factor: 6.424

Review 5.  How variability in clinical phenotypes should guide research into disease mechanisms in asthma.

Authors:  Kian Fan Chung; Ian M Adcock
Journal:  Ann Am Thorac Soc       Date:  2013-12

6.  Level of Fatty Acid Binding Protein 5 (FABP5) Is Increased in Sputum of Allergic Asthmatics and Links to Airway Remodeling and Inflammation.

Authors:  Hille Suojalehto; Pia Kinaret; Maritta Kilpeläinen; Elina Toskala; Niina Ahonen; Henrik Wolff; Harri Alenius; Anne Puustinen
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

7.  Invariant Natural Killer T Cells Play a Role in Chemotaxis, Complement Activation and Mucus Production in a Mouse Model of Airway Hyperreactivity and Inflammation.

Authors:  Piia Karisola; Maili Lehto; Pia Kinaret; Niina Ahonen; Rita Haapakoski; Minna Anthoni; Masaru Taniguchi; Henrik Wolff; Anne Puustinen; Harri Alenius
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

8.  Decreased S100A9 Expression Promoted Rat Airway Smooth Muscle Cell Proliferation by Stimulating ROS Generation and Inhibiting p38 MAPK.

Authors:  Lei-Miao Yin; Xiao-Jie Han; Ting-Ting Duan; Yu-Dong Xu; Yu Wang; Luis Ulloa; Yong-Qing Yang
Journal:  Can Respir J       Date:  2016-12-05       Impact factor: 2.409

Review 9.  Resolving the etiology of atopic disorders by using genetic analysis of racial ancestry.

Authors:  Jayanta Gupta; Elisabet Johansson; Jonathan A Bernstein; Ranajit Chakraborty; Gurjit K Khurana Hershey; Marc E Rothenberg; Tesfaye B Mersha
Journal:  J Allergy Clin Immunol       Date:  2016-06-11       Impact factor: 10.793

10.  Comparative proteomics of inhaled silver nanoparticles in healthy and allergen provoked mice.

Authors:  Chien-Ling Su; Tzu-Tao Chen; Chih-Cheng Chang; Kai-Jen Chuang; Cheng-Kuan Wu; Wen-Te Liu; Kin Fai Ho; Kang-Yun Lee; Shu-Chuan Ho; Hsiu-Er Tseng; Hsiao-Chi Chuang; Tsun-Jen Cheng
Journal:  Int J Nanomedicine       Date:  2013-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.